This is an investigational study of CAR2 Anti-CD38 A2 CAR-T Cells in patients with Relapsed or Refractory Multiple Myeloma. The treatment uses your own T cells to try to kill your cancerous multiple myeloma cells.
Sorrento Therapeutics, Inc.
Create your account today and get matched to myeloma treatments and trials around the US.
Weekdays 9am - 5pm EST